The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(Thiophen-2-ylmethyl)-1-(3,5-dichlorobenzoyl)-4-(isoquinoline-4-carbonyl)Piperazine-2-carboxyamide ID: ALA5188502
PubChem CID: 168281126
Max Phase: Preclinical
Molecular Formula: C26H22Cl2N4O2S
Molecular Weight: 525.46
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1cccs1)[C@@H]1CN(C(=O)c2cncc3ccccc23)CCN1c1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C26H22Cl2N4O2S/c27-22-8-7-18(12-23(22)28)32-10-9-31(16-24(32)25(33)30-14-19-5-3-11-35-19)26(34)21-15-29-13-17-4-1-2-6-20(17)21/h1-8,11-13,15,24H,9-10,14,16H2,(H,30,33)/t24-/m0/s1
Standard InChI Key: RINFEVYWSYRNHT-DEOSSOPVSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
-2.2502 1.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8379 0.6909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2496 -0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0750 -0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4867 0.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0787 1.4055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4912 2.1201 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.3118 0.6891 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.0126 0.6909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6001 1.4056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2250 1.4056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6375 0.6909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2250 -0.0235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6001 -0.0235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4628 0.6909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8754 1.4056 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8754 -0.0237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7006 -0.0239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1113 -0.7367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6986 -1.4516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8775 -1.4532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4610 -0.7413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0126 -0.7383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6001 -1.4529 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8379 -0.7383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2504 -1.4529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0757 -1.4529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5604 -2.1201 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-4.3449 -1.8653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3449 -1.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5604 -0.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1118 0.6857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9347 0.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3449 -0.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9375 -0.7373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
6 7 1 0
5 8 1 0
2 9 1 0
10 9 1 0
11 10 1 0
12 11 1 0
13 12 1 0
14 13 1 0
9 14 1 0
12 15 1 0
15 16 2 0
15 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
14 23 1 1
23 24 2 0
23 25 1 0
25 26 1 0
26 27 1 0
28 27 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 27 2 0
18 32 1 0
33 32 2 0
34 33 1 0
35 34 2 0
19 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 525.46Molecular Weight (Monoisotopic): 524.0841AlogP: 5.25#Rotatable Bonds: 5Polar Surface Area: 65.54Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.11CX Basic pKa: 3.94CX LogP: 4.73CX LogD: 4.73Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: -1.92
References 1. Gao S, Sylvester K, Song L, Claff T, Jing L, Woodson M, Weiße RH, Cheng Y, Schäkel L, Petry M, Gütschow M, Schiedel AC, Sträter N, Kang D, Xu S, Toth K, Tavis J, Tollefson AE, Müller CE, Liu X, Zhan P.. (2022) Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity., 65 (19.0): [PMID:36107752 ] [10.1021/acs.jmedchem.2c01146 ]